Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2023.12.29.573608

The evolution of fitness during range expansions in multiple dimensions

Kotsar, Y.·Matsuoka, H.·Tamiya, G.
View original source ↗Export metadata ↓

Abstract

We develop a set of programs - the range expansions simulation kit (RESK) - to efficiently simulate range expansions of populations on a square lattice in 1D, 2D (on a strip, and on a disk) and 3D (in a cylinder, and in a sphere). In this study, we present the simulation kit to the public and present some results of using it to simulate a population of diploid individuals with finite genome regions, each containing infinite sites. Specifically, using the programs, we calculate and analyse the temporal evolution of population fitness, as well as fitness on the expansion front, in 3D for the first time. We explore the model over different conditions, compare normalisation methods for fitness, and explore the case of radial (sphere) and axial (cylinder) expansions in 3D, which might apply in the analysis of the different real-life populations, such as viruses/bacteria inside a host, marine species in ocean environments, and potentially in future space colonization planning. In 3D expansions, we find complex spatial fluctuations in deme-average fitness values, different from those in radial 2D expansions. In axial 3D (cylinder) expansions, we determine that the highest-valued deme-average fitness lies along the axis of the expansion. We also find the fluctuation patterns of fitness in 3D cylinder expansions, similar to those previously seen in radial expansions in 2D. In radial 2D (disk) expansions, we find that the fitness of a population undergoing multiple mutations shows a smooth combination of binary segregation pictures against each of those mutations. We confirm the accumulation of deleterious mutations -- a phenomenon known as expansion load -- in all scenarios above. We present the software used in the above to the public as a Julia repository, ready to use with different functions for simulating range expansions with minimal syntax.

Explore related subjects

geneticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kotsar, Y., Matsuoka, H., Tamiya, G.. 2023-12-29. The evolution of fitness during range expansions in multiple dimensions. https://doi.org/10.1101/2023.12.29.573608

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗
bioRxiv2026

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗
bioRxiv2026

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗